Takeda’s Oveporexton Receives FDA Priority Review...
Category : Approval/Launch 12 February 2026Takeda announced that the US FDA has accepted its New Drug Application (NDA) for oveporexton (TAK-86...
Takeda announced that the US FDA has accepted its New Drug Application (NDA) for oveporexton (TAK-86...
Innocan Pharma Corporation has published new clinical data in Frontiers in Veterinary Science demons...
Japan has emerged as Asia’s top performer in FDA novel-drug approvals. Between 2015 and 2023,...
"Tenpoint Therapeutics Ltd, a global and commercial biotechnology company focused on developing...
"Almirall, S.A, a global pharmaceutical company dedicated to medical dermatology announced that...